BioPlus Acquisition logo
BioPlus Acquisition
BIOS | NASDAQ
Chart Builder DCF Calculator
$10.79
-$0.01 (-0.09%)
At close: Oct 06, 2023, 03:46 PM ET

BioPlus Acquisition Company Profile

Company profile explained

Company Profile

Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction. This targeted consolidation is specifically aimed at one or more entities within the vibrant life sciences industry. The corporation was formally established in 2021 and maintains its principal executive offices in New York, New York.

Key Executives

Name Position
Ross Haghighat Chief Executive Officer, Chief Financial Officer & Director

Latest SEC Filings

No SEC filings available
View All SEC Filings ➞
BioPlus Acquisition
BioPlus Acquisition logo
Country United States
IPO Date Jan 28, 2022
Industry Shell Companies
Sector Financial Services
Employees n/a
CEO R. Ross Haghighat

Contact Details

260 Madison Avenue New York City, New York 10026 United States

Stock Details

Ticker Symbol BIOS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001856653
CUSIP Number 09069N108
ISIN Number KYG112171171
SIC Code 6770

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.